These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23401595)

  • 1. Paracaspase MALT1 deficiency protects mice from autoimmune-mediated demyelination.
    Mc Guire C; Wieghofer P; Elton L; Muylaert D; Prinz M; Beyaert R; van Loo G
    J Immunol; 2013 Mar; 190(6):2896-903. PubMed ID: 23401595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.
    Bornancin F; Renner F; Touil R; Sic H; Kolb Y; Touil-Allaoui I; Rush JS; Smith PA; Bigaud M; Junker-Walker U; Burkhart C; Dawson J; Niwa S; Katopodis A; Nuesslein-Hildesheim B; Weckbecker G; Zenke G; Kinzel B; Traggiai E; Brenner D; Brüstle A; St Paul M; Zamurovic N; McCoy KD; Rolink A; Régnier CH; Mak TW; Ohashi PS; Patel DD; Calzascia T
    J Immunol; 2015 Apr; 194(8):3723-34. PubMed ID: 25762782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.
    Brüstle A; Brenner D; Knobbe CB; Lang PA; Virtanen C; Hershenfield BM; Reardon C; Lacher SM; Ruland J; Ohashi PS; Mak TW
    J Clin Invest; 2012 Dec; 122(12):4698-709. PubMed ID: 23114599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.
    Jaworski M; Marsland BJ; Gehrig J; Held W; Favre S; Luther SA; Perroud M; Golshayan D; Gaide O; Thome M
    EMBO J; 2014 Dec; 33(23):2765-81. PubMed ID: 25319413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
    Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
    J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation.
    Gewies A; Gorka O; Bergmann H; Pechloff K; Petermann F; Jeltsch KM; Rudelius M; Kriegsmann M; Weichert W; Horsch M; Beckers J; Wurst W; Heikenwalder M; Korn T; Heissmeyer V; Ruland J
    Cell Rep; 2014 Nov; 9(4):1292-305. PubMed ID: 25456129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination.
    Hisahara S; Yuan J; Momoi T; Okano H; Miura M
    J Exp Med; 2001 Jan; 193(1):111-22. PubMed ID: 11136825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
    Wexler AG; Frielle C; Berry G; Budgeon LR; Baccon J; Christensen ND; Waldner H
    J Neuroimmunol; 2013 Feb; 255(1-2):60-9. PubMed ID: 23269203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.
    Afonina IS; Elton L; Carpentier I; Beyaert R
    FEBS J; 2015 Sep; 282(17):3286-97. PubMed ID: 25996250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20.
    Coornaert B; Baens M; Heyninck K; Bekaert T; Haegman M; Staal J; Sun L; Chen ZJ; Marynen P; Beyaert R
    Nat Immunol; 2008 Mar; 9(3):263-71. PubMed ID: 18223652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Paracaspase MALT1.
    Hachmann J; Salvesen GS
    Biochimie; 2016 Mar; 122():324-38. PubMed ID: 26386283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination.
    Mc Guire C; Volckaert T; Wolke U; Sze M; de Rycke R; Waisman A; Prinz M; Beyaert R; Pasparakis M; van Loo G
    J Immunol; 2010 Dec; 185(12):7646-53. PubMed ID: 21068410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.
    Shaw MA; Gao Z; McElhinney KE; Thornton S; Flick MJ; Lane A; Degen JL; Ryu JK; Akassoglou K; Mullins ES
    J Neurosci; 2017 Apr; 37(14):3776-3788. PubMed ID: 28275164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad?
    Demeyer A; Staal J; Beyaert R
    Trends Mol Med; 2016 Feb; 22(2):135-150. PubMed ID: 26787500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
    Demeyer A; Skordos I; Driege Y; Kreike M; Hochepied T; Baens M; Staal J; Beyaert R
    Front Immunol; 2019; 10():1898. PubMed ID: 31474984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells.
    Hilliard B; Samoilova EB; Liu TS; Rostami A; Chen Y
    J Immunol; 1999 Sep; 163(5):2937-43. PubMed ID: 10453042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALT1 Controls Attenuated Rabies Virus by Inducing Early Inflammation and T Cell Activation in the Brain.
    Kip E; Staal J; Verstrepen L; Tima HG; Terryn S; Romano M; Lemeire K; Suin V; Hamouda A; Kalai M; Beyaert R; Van Gucht S
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29367251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
    Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
    J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
    Thakker P; Marusic S; Stedman NL; Lee KL; McKew JC; Wood A; Goldman SJ; Leach MW; Collins M; Kuchroo VK; Wolf SF; Clark JD; Hassan-Zahraee M
    J Immunol; 2011 Aug; 187(4):1986-97. PubMed ID: 21746963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.